Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 4;11(2):960-977.
doi: 10.1039/d0ra08901j. eCollection 2020 Dec 24.

Immune response and possible therapeutics in COVID-19

Anindya Dutta  1 , Ananya Roy  1 , Laboni Roy  1 , Samit Chattopadhyay  2 , Subhrangsu Chatterjee  1
Affiliations
Review

Immune response and possible therapeutics in COVID-19

Anindya Dutta et al. RSC Adv. .

Abstract

COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop therapies that target the SARS-CoV2 virus specifically. This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1. Immune response and cytokine storm in COVID-19.
Fig. 2
Fig. 2. Action of putative repurposable drugs along the infection pathway.
See this image and copyright information in PMC

References

    1. Guo Y.-R. Cao Q.-D. Hong Z.-S. Tan Y.-Y. Chen S.-D. Jin H.-J. Tan K.-S. Wang D.-Y. Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil. Med. Res. 2020;7:11. - PMC - PubMed
    1. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19) Indian J. Pediatr. 2020;87:281–286. doi: 10.1007/s12098-020-03263-6. - DOI - PMC - PubMed
    1. Zu Z. Y. Jiang M. D. Xu P. P. Chen W. Ni Q. Q. Lu G. M. Zhang L. J. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020;296:E15–E25. doi: 10.1148/radiol.2020200490. - DOI - PMC - PubMed
    1. Tahir Ul Qamar M. Alqahtani S. M. Alamri M. A. Chen L.-L. Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal. 2020;10:313–319. doi: 10.1016/j.jpha.2020.03.009. - DOI - PMC - PubMed
    1. Prasad S. Potdar V. Cherian S. Abraham P. Basu A. Team I.-N. N. Transmission electron microscopy imaging of SARS-CoV-2. Indian J. Med. Res. 2020;151:241–243. - PMC - PubMed